Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease
Overview of Darke PL et al.
Authors | Darke PL Leu CT Davis LJ Heimbach JC Diehl RE Hill WS Dixon RA Sigal IS |
---|---|
Affiliation | Department of Molecular Biology Merck Sharp and Dohme Research Laboratories West Point Pennsylvania 19486. |
Journal | J Biol Chem |
Year | 1989 |
Abstract
The protease of human immunodeficiency virus has been expressed in Escherichia coli and purified to apparent homogeneity. Immunoreactivity toward anti-protease peptide sera copurified with an activity that cleaved the structural polyprotein gag p55 and the peptide corresponding to the sequence gag 128-135. The enzyme expressed as a nonfusion protein exhibits proteolytic activity with a pH optimum of 5.5 and is inhibited by the aspartic protease inhibitor pepstatin with a Ki of 1.1 microM. Replacement of the conserved residue Asp-25 with an Asn residue eliminates proteolytic activity. Analysis of the minimal peptide substrate size indicates that 7 amino acids are required for efficient peptide cleavage. Size exclusion chromatography is consistent with a dimeric enzyme and circular dichroism spectra of the purified enzyme are consistent with a proposed structure of the protease (Pearl, L.H., and Taylor, W.R. (1987) Nature 329, 351-354). These data support the classification of the human immunodeficiency virus protease as an aspartic protease, likely to be structurally homologous with the well characterized family that includes pepsin and renin.